Patent application number | Description | Published |
20100141654 | Device and Method for Displaying Feature Marks Related to Features in Three Dimensional Images on Review Stations - A system is provided for displaying information associated with at least one feature of a three-dimensional image. The three-dimensional image is apportioned along a plane into a plurality of 2-D image slices and a display is provided for viewing the 2-D image slices. A feature window of the present invention is positioned together with a 2-D image display. The feature window displays feature distribution along a plane normal to the plane of the 2-D image slices for one or more regions of interest, thereby increasing reviewing efficiency by enabling visualization of three-dimensions of information using a 2 dimensional display. As a result a reviewer is able to quickly identify image slices with the most pertinent feature information and diagnostic efficiency and accuracy is greatly increased. | 06-10-2010 |
20100150417 | PROCESSING MEDICAL IMAGES OF THE BREAST TO DETECT ANATOMICAL ABNORMALITIES THEREIN - Methods, systems and related computer program products are provided for processing a medical image of a breast to detect anatomical abnormalities therein, including anatomical abnormalities that may be associated with breast cancer. The medical image of the breast, which includes a background region bordering a breast tissue region along a skinline thereof, is processed to detect an inward-facing retraction along the skinline, which can be potentially indicative of an anatomical abnormality in the breast tissue. In one preferred embodiment, a display monitor displays first information representative of the medical image of the breast and second information identifying a location of the detected inward-facing retraction on the medical image of the breast. In another preferred embodiment, one or more metrics characterizing the detected inward-facing retraction are used as features in the classification of potential CAD detections in the breast tissue region. | 06-17-2010 |
20140327702 | SYSTEM AND METHOD FOR GENERATING A 2D IMAGE USING MAMMOGRAPHY AND/OR TOMOSYNTHESIS IMAGE DATA - The invention includes a method including the steps of obtaining a plurality of images, each of the images in the plurality having at least one corresponding region, generating a merged image, the merged image also having the corresponding region. The step of generating includes selecting an image source from the plurality of images to source image data for the corresponding region in the merged image by comparing attributes of the corresponding regions of the plurality of images to identify the image source having preferred attributes. | 11-06-2014 |
Patent application number | Description | Published |
20130259756 | CHEMICAL OXYGEN GENERATOR WITH CHEMICAL CORES ARRANGED IN PARALLEL - A chemical oxygen generator includes multiple parallel sequentially connected chemical core sections that extend the duration of operation of the chemical oxygen generator. An end of a first core section is contiguous with a chemical core high reactivity section, and a thermal insulation layer is disposed between an end of a second core section and the chemical core ignition plate, as well as between the bodies of the first and second core sections. A chemical core transition section is disposed between the other end of the first core section and the second core section, to insure that the reaction front propagates properly. | 10-03-2013 |
20130312743 | ON-BOARD GENERATION OF OXYGEN FOR AIRCRAFT PASSENGERS - The present invention provides a system and method for supplying, generating, conserving, and managing oxygen that is ideally suited for use on-board an aircraft for supply of breathable oxygen to passengers and flight crew. The system includes several components that together optimize oxygen utilization while reducing costs from maintenance and added weight of traditional pressurized gaseous cylinders. Components of the system include a pressurized cylinder of oxygen enriched gas or a chemical oxygen generator for rapid use in emergency situations, an on-board oxygen generator (OBOG) of the ceramic oxygen generator (COG) type incorporating solid electrolyte oxygen separation (SEOS) technology, a controller, a pulsed oxygen supplier, a crew/passenger breathing mask, and one or more sensors including sensors that detect inhale/exhale phases and communicate with the controller so that flow of oxygen may be regulated for conservation and to adapt to physiological needs. | 11-28-2013 |
20130312744 | ON-BOARD GENERATION OF OXYGEN FOR AIRCRAFT PILOTS - The present invention provides a system and method for supplying and managing oxygen suited for use on-board an aircraft for providing breathable oxygen to pilots and cockpit crew. Components of the system work together to optimize oxygen utilization while reducing costs from maintenance and added weight of traditional pressurized gaseous cylinders. Components include a rapid oxygen supply for immediate use in emergency situations, an on-board oxygen generator (OBOG), a controller, a pulsed oxygen delivery subsystem that detects inhale/exhale phases and adapts to physiological requirements, and a breathing mask for each pilot and cockpit crew member. | 11-28-2013 |
20130312745 | HYBRID ON-BOARD GENERATION OF OXYGEN FOR AIRCRAFT PASSENGERS - Provided herein is a hybrid system for generating oxygen on-board an aircraft for passengers and/or flight crew to breath. The system includes a first chemical oxygen generator component configured to promptly supply oxygen suitable for breathing upon an emergency situation arising and during an initial descent mode. Heat produced from the exothermic decomposition reactions inherent in several types of chemical oxygen generators can be harvested and feed to a second oxygen generator. The second oxygen generator is a solid electrolyte oxygen separation system that catalytically separates oxygen from air inside specialized ceramic materials at high temperatures, about 650° C. to 750° C., using electrical voltage. The ability to feed heat from the first oxygen generator to the second oxygen generator substantially reduces the lag time until the second ceramic oxygen generator is available to take over as the oxygen supply. | 11-28-2013 |
20140241961 | CHEMICAL OXYGEN GENERATOR WITH CHEMICAL CORES ARRANGED IN PARALLEL - A chemical oxygen generator includes multiple parallel sequentially connected chemical core sections that extend the duration of operation of the chemical oxygen generator. An end of a first core section is contiguous with a chemical core high reactivity section, and a thermal insulation layer is disposed between an end of a second core section and the chemical core ignition plate, as well as between the bodies of the first and second core sections. A chemical core transition section is disposed between the other end of the first core section and the second core section, to insure that the reaction front propagates properly. | 08-28-2014 |
Patent application number | Description | Published |
20090268915 | Secure Creation and Management of Device Ownership Keys - Secure creation and management of device ownership keys. TPM ownership keys are generated by cryptographically combining manufacturer information with device specific information. Ownership keys are established in the TPM containing device. The manufacturer retains necessary information to reconstruct the ownership key if needed. | 10-29-2009 |
20100131694 | Secure Boot ROM Emulation - Secure boot ROM emulation with locking storage device. A locking storage device is provided by combining a nonvolatile memory device such as flash or EEPROM with one-shot locking logic which write enables at least a portion of the nonvolatile memory device upon power cycling of the overall digital device. This write enable is cleared during the stage 1 bootloader process, thus providing a protected update interval for updating a stage 2 bootloader once per power cycle. | 05-27-2010 |
20100313262 | PROVISIONING REMOTE ACCESS POINTS - Provisioning remote access points for use in a telecommunication network. A remote access point contains identity information established during manufacturing; this identity information may be in the nature of a digital certificate. The identity information is stored in the remote access point, and may be stored in a Trusted Platform Module if present. When the remote access node is powered up in unprovisioned state, outside the manufacturing environment, it attempts to establish an internet connection via a first wired interface, and queries a user for information representing the TCP/IP address of its controller via a second wired interface. Once an internet connection is present, and a TCP/IP address has been provided, the remote access point attempts to connect to the controller at that address. The controller may filter connection requests through a whitelist of approved remote access points. Once a connection is established, controller and access point exchange and verify each other's identities. This may be done through the exchange and verification of digital certificates. Provisioning information is downloaded from controller to remote access point and installed. This may be done via a tunnel such as an encrypted tunnel. Software updates may be applied. The provisioned remote access point is placed in operation. | 12-09-2010 |
20110029771 | Enrollment Agent for Automated Certificate Enrollment - Automated generation of certificates from a Certificate Authority through the use of an Enrollment Agent. Devices needing certificates generate the necessary keys and package public key information with other identifying information about the device and send this information to an Enrollment Agent. The Enrollment Agent takes this information and submits it on behalf of the device to a Certificate Authority, managing the interaction with the Certificate Authority on behalf of the device. The Certificate Authority signs the request, returning a certificate to the Enrollment Agent. The Enrollment Agent packages the certificate along with the other certificates needed to establish a chain of trust and returns these to the device. Certificates may be stored in the device in flash memory. The process is secure as long as the communications path between the devices and the Enrollment Agent is secure; a secure VPN or HTTPS: connection allows the devices and the Enrollment Agent to be in separate locations. | 02-03-2011 |
20110252237 | Authorizing Remote Access Points - Authorizing remote access points for use in a network: A remote access point contains identity information established during manufacturing; this identity information may be in the nature of a digital certificate which can be used to establish a secure connection between networked entities. After the remote access point is provisioned to communicate securely to a controller using its TCP/IP address provided by a user, the remote access point is put into an un-authorized state by the controller pending further authorization. The user is presented with a secure captive portal page authenticating the end-user. This authorization may be through entering a user name and password, through presenting a certificate, through two-factor methods, or other methods known to the art. User's authentication credentials are verified by the controller. Optionally this verification can be performed using a per-user certificate. After the remote access point has been authorized, the controller marks it verified as a fully functional node, and saves this state. The user performing the authorization is associated with the remote access point, and may be used to monitor the usage and potentially revoke the authorization. The remote access point is provisioned with the current provisioning parameters for the remote access point as configured by the IT administrator for the end user, so that each remote access point can have unique per-user configuration applied. | 10-13-2011 |
20140082060 | Provisioning Remote Access Points - Provisioning remote access points for use in a telecommunication network. A remote access point contains identity information established during manufacturing; this identity information may be in the nature of a digital certificate. The identity information is stored in the remote access point, and may be stored in a Trusted Platform Module if present. When the remote access node is powered up in unprovisioned state, outside the manufacturing environment, it attempts to establish an internet connection via a first wired interface, and queries a user for information representing the TCP/IP address of its controller via a second wired interface. Once an internet connection is present, and a TCP/IP address has been provided, the remote access point attempts to connect to the controller at that address. Once a connection is established, controller and access point exchange and verify each other's identities. | 03-20-2014 |
20140173700 | SYSTEM AND METHOD FOR APPLICATION USAGE CONTROLS THROUGH POLICY ENFORCEMENT - A method includes a particular user application, without operating system kernel access, performing the operations of: identifying a set of applications that a user has permission to access, receiving a request to a access a particular application of the set of applications, and causing execution of the particular application. | 06-19-2014 |
Patent application number | Description | Published |
20120071463 | HYDROXY AND ALKOXY SUBSTITUTED 1H-IMIDAZOQUINOLINES AND METHODS - 1H-Imidazo[4,5-c]quinolin-4-amines with a hydroxy, alkoxy, hydroxyalkoxy, or alkoxyalkoxy substituent at the 2-position, pharmaceutical compositions containing these compounds, methods of making the compounds, intermediates, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed. | 03-22-2012 |
20120121651 | PYRAZOLOPYRIDINES AND ANALOGS THEREOF - Pyrazolopyridin-4-amines, pyrazoloquinolin-4-amines, pyrazolonaphthyridin-4-amines, 6,7,8,9-tetrahydropyrazoloquinolin-4-amines, and prodrugs thereof, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed. | 05-17-2012 |